human

Editage showcases the Power of AI + Human Collaboration at the Global Research Council 2025

MUMBAI, India, Nov. 27, 2025 /PRNewswire/ -- Editage, the flagship brand of Cactus Communications (CACTUS), a leader in AI and expert…

10 hours ago

Crypto Mondays Austin Presents: Regenerative Wealth Where Blockchain, Wellness, Fashion, and Human Potential Meet

Austin, TX, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Crypto Mondays Austin announces Regenerative Wealth, an innovative gathering that merges technology,…

6 days ago

Abnormal AI Strengthens Threat Detection for German Business Communication with Enhanced Localization

MUNICH--(BUSINESS WIRE)--Abnormal AI, the leader in AI-native human behavior security, today announced enhanced localization of its behavioral AI to strengthen…

1 week ago

NooCube | Nootropics Brain Booster 2025: Lunch Noocube Brain Productivity Pills for Memory, Focus, Read Ingredients & Side Effects.

New York City, Nov. 16, 2025 (GLOBE NEWSWIRE) -- November 14, 2025, Noocube Brain Productivity Nootropics Brain Health Supplement lunch…

2 weeks ago

Firstsource Strengthens UnBPO Vision with Strategic Investment in Lyzr.ai

MUMBAI, India, Nov. 4, 2025 /PRNewswire/ -- Firstsource Solutions Limited (NSE: FSL) (BSE: 532809), a leading global provider of business process management…

3 weeks ago

Lucas GC Limited Announces 1H 2025 Financial Results: Revenue at US$54.01 million with Increases in Gross Margin

October 31, 2025 17:00 ET  | Source: Lucas GC Limited NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Lucas GC…

4 weeks ago

450+ years of tradition of scholarly excellence: Queen Elizabeth’s School, Dubai Sports City to Open August 2026

DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- Building on more than 450 years of academic excellence in the UK, Queen Elizabeth's…

4 weeks ago

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…

4 weeks ago

Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc

Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose metabolismRobust…

1 month ago

Joget Unlocks Autonomous Productivity Across HR, Procurement, Customer Service, and Supply Chain with No-Code AI Agent Builder

Joget AI Agent Builder enables teams across every department to create goal-driven agents that execute autonomously, yet remain governed by…

1 month ago